Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Germline Testing for Predisposition to Myeloid Malignancies [NA]

View source ↗

Summary

Ongoing recruitment for a germline genetic testing study aimed at identifying predisposition to myeloid malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Christopher Reilly | Conditions: Myeloid Malignancy, Genetic Predisposition to Disease | NA | Status: RECRUITING